FLIP antibody (AA 181-230)
Quick Overview for FLIP antibody (AA 181-230) (ABIN1450917)
Target
See all FLIP (CFLAR) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 181-230
-
Specificity
-
CFLAR Antibody detects endogenous levels of CFLAR.
-
Purification
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
-
Purity
- > 95 %
-
Immunogen
- The antiserum was produced against synthesized peptide derived from human CFLAR.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:10000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable at -20°C for at least 1 year.
-
Expiry Date
- 12 months
-
-
- FLIP (CFLAR) (CASP8 and FADD-Like Apoptosis Regulator (CFLAR))
-
Alternative Name
- CFLAR
-
Background
-
Synonyms: c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS, CASH, CASP8 and FADD-like apoptosis regulator, CASP8AP1, caspase homolog, caspase-eight-related, caspase-like apoptosis regulatory, caspase-related inducer of apoptosis, casper, cellular FLICE-like inhibitory, CLARP, FAD
NCBI Gene Symbol: CFLAR
-
Molecular Weight
- 55 kDa
-
Gene ID
- 8837
-
OMIM
- 603599
-
UniProt
- O15519
-
Pathways
- Apoptosis, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Target
-